Skip to menu Skip to content Skip to footer

1999

Conference Publication

Identification and characterisation of the hepatic stellate cell transferrin receptor and influence of transferrin on hepatic stellate cell activation

Bridle, K., Stewart, N. L., Crawford, D. H., Anderson, G. and Ramm, G. A. (1999). Identification and characterisation of the hepatic stellate cell transferrin receptor and influence of transferrin on hepatic stellate cell activation. Bioiron'99, Sorrento Palace, Sorrento-Naples, Italy, 23 - 28 May 1999. Italy: SGC.

Identification and characterisation of the hepatic stellate cell transferrin receptor and influence of transferrin on hepatic stellate cell activation

1999

Conference Publication

Hepatic stellate cells are responsible for increased type I collagen production leading to cirrhosis in cystic fibrosis liver disease

Blanch, N. L., Greco, S., Lewindon, P., Ramm, G. A., Shepherd, R. W., Smith, J. L. and Walker, N. I. (1999). Hepatic stellate cells are responsible for increased type I collagen production leading to cirrhosis in cystic fibrosis liver disease. Australian Gastroenterology Week 1999, Brisbane, 4 - 8 October, 1999. Carlton, Vic: Blackwell Science.

Hepatic stellate cells are responsible for increased type I collagen production leading to cirrhosis in cystic fibrosis liver disease

1999

Conference Publication

Serum collagen type IV and hyaluronic acid as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases

Ramm, G. A., Murphy, T. L., Fanning, P. A., Clouston, A. D., George, D. K., Fletcher, L. M., Anderson, G., Powell, L. W. and Crawford, D. H. (1999). Serum collagen type IV and hyaluronic acid as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases. Bioiron'99, Sorrento Palace, Sorrento - Naples, Italy, 23 - 28 May 1999. Italy: SGC.

Serum collagen type IV and hyaluronic acid as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases

1999

Conference Publication

Hepatic iron overload in pathogen-free gerbils does not result in bridging fibrosis or cirrhosis

Ramm, G. A., Britton, R. S., Brunt, E. M., O'Neil, R. and Bacon, B. R. (1999). Hepatic iron overload in pathogen-free gerbils does not result in bridging fibrosis or cirrhosis. Bioiron'99, Sorrento Palace, Sorrento - Naples, Italy, 23 - 28 May 1999. Italy: SGC.

Hepatic iron overload in pathogen-free gerbils does not result in bridging fibrosis or cirrhosis

1999

Conference Publication

Identification and characterisation of a receptor for transferrin on hepatic stellate cells: role in the transformation to myofibroblasts

Bridle, K., Blanch, N. L., Crawford, D. H. and Ramm, G. A. (1999). Identification and characterisation of a receptor for transferrin on hepatic stellate cells: role in the transformation to myofibroblasts. Australian Gastroenterology Week 1999, Brisbane, 4 - 8 Oct, 1999. Carlton, Vic: Blackwell Science Asia.

Identification and characterisation of a receptor for transferrin on hepatic stellate cells: role in the transformation to myofibroblasts

1999

Conference Publication

Evaluation of serum TIMP-1 collagen type IV and MMP-2 as markers of hepatic fibrogenesis in cystic fibrosis liver

Lewindon, P., Murphy, T. M., Pereira, T., Ramm, G. A., Shepherd, R. W. and Smith, J. L. (1999). Evaluation of serum TIMP-1 collagen type IV and MMP-2 as markers of hepatic fibrogenesis in cystic fibrosis liver. Australian Gastroenterology Week 1999, Brisbane, Australia, 4-8 October 1999. Carlton, Vic: Blackwell Science.

Evaluation of serum TIMP-1 collagen type IV and MMP-2 as markers of hepatic fibrogenesis in cystic fibrosis liver

1999

Conference Publication

Serum hyaluronic acid and collagen type IV as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases American Association for the Study of Liver Diseases (AASLD) 50th annual meeting. Texas, USA. November 5-9, 1999.

Ramm, G.A., Murphy, T.L., Fanning, P.A., Clouston, A.D., Anderson, G.J. and Crawford, D.H. (1999). Serum hyaluronic acid and collagen type IV as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases American Association for the Study of Liver Diseases (AASLD) 50th annual meeting. Texas, USA. November 5-9, 1999.. 50th Annual Meeting American Association for the Study of Liver Disease, Dallas, TX, United States, 5-9 November 1999. Hoboken, NJ, United States: John Wiley & Sons.

Serum hyaluronic acid and collagen type IV as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases American Association for the Study of Liver Diseases (AASLD) 50th annual meeting. Texas, USA. November 5-9, 1999.

1999

Conference Publication

Serum hyaluronic acid and collagen type IV as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases

Ramm, G. A., Murphy, T. L., Fanning, P. A., Clouston, A. D., George, D. K., Fletcher, L. M., Anderson, G., Powell, L. W. and Crawford, D. H. (1999). Serum hyaluronic acid and collagen type IV as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases. American Assoc. for the Study of Liver Diseases 50th Annual Meeting, Dallas, Texas, USA, 5 - 9 Nov, 1999. USA: W B Saunders Co..

Serum hyaluronic acid and collagen type IV as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases

1999

Conference Publication

Activated hepatic stellate cells produce increased collagen type I in patients with cystic fibrosis liver disease

Smith, J. L., Ramm, G. A., Lewindon, P. and Blanch, N. L. (1999). Activated hepatic stellate cells produce increased collagen type I in patients with cystic fibrosis liver disease. Basel, Switzerland, Oct 1999. Switzerland: Congress for Liver Disease.

Activated hepatic stellate cells produce increased collagen type I in patients with cystic fibrosis liver disease

1999

Conference Publication

Serum hyaluronic acid is a sensitive marker of both cirrhosis in haemochromatosis and liver injury in other chronic liver diseases

Ramm, G. A., Murphy, T. L., Fanning, P. A., Clouston, A. D., George, D. K., Fletcher, L. M., Anderson, G., Powell, L. W. and Crawford, D. H. (1999). Serum hyaluronic acid is a sensitive marker of both cirrhosis in haemochromatosis and liver injury in other chronic liver diseases. Australian Gastroenterology Week 1999, Brisbane, 4 - 8 October,1999. Carlton, Vic: Blackwell Science Asia.

Serum hyaluronic acid is a sensitive marker of both cirrhosis in haemochromatosis and liver injury in other chronic liver diseases

1999

Conference Publication

Hepatic fibrogenesis in cystic fibrosis liver disease

Blanch, N. L., Bridle, K., Greco, S., Lewindon, P., Murphy, T. M., Pereira, T., Ramm, G. A., Shepherd, R. W., Smith, J. L. and Walker, N. I. (1999). Hepatic fibrogenesis in cystic fibrosis liver disease. 50th Annual Meeting and Postgraduate Conference, Dallas, Texas, Nov 1999. USA: Harcourt and Brace (WD Saunders).

Hepatic fibrogenesis in cystic fibrosis liver disease

1999

Conference Publication

Hepatic stellate cells and hepatic fibrogenesis in cystic fibrosis liver disease

Greco, S., Lewindon, P., Ramm, G. A. and Shepherd, R. W. (1999). Hepatic stellate cells and hepatic fibrogenesis in cystic fibrosis liver disease. Thirteenth Annual North American Cystic Fibrosis Conference, Washington State Convention and Trade Cen., Seattle, Washington USA, 7 - 10 October, 1999. California, USA: Wiley-Liss. doi: 10.1002/(SICI)1099-0496(199909)28:19

Hepatic stellate cells and hepatic fibrogenesis in cystic fibrosis liver disease

1998

Conference Publication

Ferritin increases PKC-zeta expression in early rat hepatic stellate cell activation

Ramm, G.A., Coomer, J.M., Watters, D.J. and Crawford, D.H.G. (1998). Ferritin increases PKC-zeta expression in early rat hepatic stellate cell activation. 49th Annual Meeting of the American Association for the Study of Liver Disease, Chicago, Il, United States, 6-10 November 1998. Hoboken, NJ, United States: John Wiley & Sons.

Ferritin increases PKC-zeta expression in early rat hepatic stellate cell activation

1998

Conference Publication

The contribution of inflammatory cells to iron-induced hepatic fibrogenesis in hemochromatosis

Bridle, K. R., Crawford, D. H. G., Smith, J. L., Fletcher, L. M., Walker, N. I. and Ramm, G. A. (1998). The contribution of inflammatory cells to iron-induced hepatic fibrogenesis in hemochromatosis. 49th Annual Meeting of the American Association for the Study of Liver Disease, Chicago, Il, United States, 6-10 November 1998. Hoboken, NJ, United States: John Wiley & Sons.

The contribution of inflammatory cells to iron-induced hepatic fibrogenesis in hemochromatosis

1997

Conference Publication

Contribution of parenchymal and non-parenchymal cells to hepatic fibrogenesis in biliary atresia

Ramm, G.A., Shepherd, R.W. and Crawford, D.H.G. (1997). Contribution of parenchymal and non-parenchymal cells to hepatic fibrogenesis in biliary atresia. 48th Annual Meeting of the American Association for the Study of Liver Disease, Chicago, Il, United States, 7-11 November 1997. Hoboken, NJ, United States: John Wiley & Sons.

Contribution of parenchymal and non-parenchymal cells to hepatic fibrogenesis in biliary atresia

1997

Conference Publication

In vivo hepatic activities of matrix metalloproteinases-2, 3 and 9 are increased in prefibrotic animal and human iron overload

George, D.K., Ramm, G.A., Bridle, K.R., Fletcher, L.M. and Crawford, D.H.G. (1997). In vivo hepatic activities of matrix metalloproteinases-2, 3 and 9 are increased in prefibrotic animal and human iron overload. 48th Annual Meeting of the American Association for the Study of Liver Disease, Chicago, Il, United States, 7-11 November 1997. Hoboken, NJ, United States: John Wiley & Sons.

In vivo hepatic activities of matrix metalloproteinases-2, 3 and 9 are increased in prefibrotic animal and human iron overload

1997

Conference Publication

The role of activated hepatic stellate cells in capsule formation in hepatocellular carcinoma and colorectal metastases to the liver

Ramm, G.A., Ooi, L. L. P. J., Gotley, D. C., Clouston, A. D., Bridle, K. R. and Crawford, D. H. G. (1997). The role of activated hepatic stellate cells in capsule formation in hepatocellular carcinoma and colorectal metastases to the liver. 8th International Symposium on the Cells of the Hepatic Sinusoid, Bordeaux, France, 1-5 September 1996. Leiden, Netherlands: Kupffer Cell Foundation.

The role of activated hepatic stellate cells in capsule formation in hepatocellular carcinoma and colorectal metastases to the liver

1997

Conference Publication

Interferon-gamma but not transforming growth factor-beta gene expression is upregulated in liver tissue of patients with genetic hemochromatosis

Bridle, K.R., Crawford, D.H.G., Fletcher, L.M. and Ramm, G.A. (1997). Interferon-gamma but not transforming growth factor-beta gene expression is upregulated in liver tissue of patients with genetic hemochromatosis. 48th Annual Meeting of the American Association for the Study of Liver Disease, Chicago, Il, United States, 7-11 November 1997. Hoboken, NJ, United States: John Wiley & Sons.

Interferon-gamma but not transforming growth factor-beta gene expression is upregulated in liver tissue of patients with genetic hemochromatosis

1997

Conference Publication

Role of tissue ferritin in regulation of alpha-smooth muscle actin expression in hepatic stellate cells via PKC zeta and/or nitric oxide

Ramm, G.A., Piva, T.J., Garrone, B.M., Watters, D.J. and Crawford, D.H.G. (1997). Role of tissue ferritin in regulation of alpha-smooth muscle actin expression in hepatic stellate cells via PKC zeta and/or nitric oxide. 48th Annual Meeting of the American Association for the Study of Liver Disease, Chicago, Il, United States, 7-11 November 1997. Hoboken, NJ, United States: John Wiley & Sons.

Role of tissue ferritin in regulation of alpha-smooth muscle actin expression in hepatic stellate cells via PKC zeta and/or nitric oxide

1996

Conference Publication

Enhanced hepatic lipid peroxidation in genetic hemochromatosis; reversal by phlebotomy

Houglum, K., Ramm, G.A., Crawford, D.H.G., Witztum, J., Powell, L.W. and Chojkier, M. (1996). Enhanced hepatic lipid peroxidation in genetic hemochromatosis; reversal by phlebotomy. 47th Annual Meeting of the American Association for the Study of Liver Disease, Chicago, Il, United States, 8-12 November 1996. Hoboken, NJ, United States: John Wiley & Sons.

Enhanced hepatic lipid peroxidation in genetic hemochromatosis; reversal by phlebotomy